<DOC>
	<DOC>NCT00780455</DOC>
	<brief_summary>Studying the effectiveness of a functional rehabilitation protocol (FRP) in early Relapsing Remitting Multiple Sclerosis (RRMS) patients treated with Betaferon by comparing the physical ability of patients with and without FRP.</brief_summary>
	<brief_title>Rehabilitation Study in MS Patients</brief_title>
	<detailed_description />
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis, Relapsing-Remitting</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<mesh_term>Interferon beta-1b</mesh_term>
	<criteria>Female and Male patients aged 18 and more; Confirmed diagnosis of RRMS according to the MacDonald or Poser criteria; First indication for Betaferon treatment (as described in Summary of Product Characteristics (SmPC)); No relapse of multiple sclerosis (MS) in the last two months before the inclusion; Walking patients having an Expanded Disability Status Scale (EDSS) score between &gt; 1 and &lt;/= 4 at the inclusion visit; Female of childbearing potential must agree to practice adequate contraception methods over all the duration of the study; Patient can follow all the study and comply with all procedures of the trial protocol Laboratory evaluations (i.e. evaluation of hepatic enzymes gammaGT, full blood count and differential white blood cell [WBC]) must be available and the results must be normal; Written informed consent. Any contraindication to Betaferon as described in the SmPC of the product; Patient with a previously orthopaedic surgical intervention within the past year of the inclusion; Patient previously included in this study; Patient previously treated within the past 3 months with Rebif, Avonex or Copaxone; Patient previously treated within the past 12 months with Betaferon; Participation in any clinical trial within the past 30 days involving the investigational drug intake.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>KineSEP</keyword>
	<keyword>Rehabilitation</keyword>
	<keyword>Betaferon</keyword>
</DOC>